The evolutionary background of a genetic variant like rs113488022 can be explored by examining its allele frequency across different populations, its functional impact, and its association with diseases or traits. Below is the information retrieved from the TogoVar API and additional insights based on external knowledge:

---

### 1. **Variant Identification**
- **rs Number**: rs113488022
- **Gene Name**: BRAF
- **Chromosome and Position**: Chromosome 7, position 140753336
- **HGVS Notation**: Multiple notations depending on the transcript, e.g., NM_004333.6:c.1799T>G (p.Val600Gly), NM_004333.6:c.1799T>C (p.Val600Ala), NM_004333.6:c.1799T>A (p.Val600Glu).
- **TogoVar Link**: [rs113488022 on TogoVar](https://togovar.org/variant/rs113488022)

---

### 2. **Disease Associations**
The variant rs113488022 is associated with multiple diseases, including:
- **Melanoma**: Pathogenic (P) interpretation.
- **RASopathy**: Pathogenic (P) interpretation.
- **Cardio-facio-cutaneous syndrome**: Likely pathogenic (LP) interpretation.
- **Papillary thyroid carcinoma**: Pathogenic (P) interpretation.
- **Non-small cell lung carcinoma**: Pathogenic (P) interpretation.

These associations suggest that the variant has undergone selective pressure due to its involvement in critical pathways like the MAPK signaling pathway, which is regulated by the BRAF gene.

---

### 3. **Allele Frequency Comparison**
- **Global Frequency**: Extremely rare, with an allele frequency of 1.37 × 10⁻⁶ in the gnomAD exomes dataset.
- **Japanese Population**: No specific allele frequency data for Japanese populations was retrieved from the TogoVar API.

The rarity of this variant globally suggests it may have arisen relatively recently in human evolution or is under strong negative selection due to its pathogenic effects.

---

### 4. **Functional Impact**
- **SIFT Score**: 0.0 (deleterious)
- **PolyPhen Score**: Ranges from 0.294 to 0.958 depending on the specific substitution (e.g., Val600Gly, Val600Ala, Val600Glu).
- **AlphaMissense Score**: Up to 0.9927, indicating a high likelihood of pathogenicity.

The functional impact of rs113488022 is significant, as it affects the BRAF protein, a key regulator in cell growth and differentiation. Variants at this position are known to alter kinase activity, leading to oncogenic effects.

---

### 5. **Evolutionary Insights**
- **Conservation**: The Val600 residue in BRAF is highly conserved across species, indicating its critical role in protein function.
- **Selective Pressure**: Variants at this position are often associated with diseases, suggesting that mutations here are under purifying selection in healthy populations.
- **Disease-Driven Evolution**: The presence of pathogenic variants like rs113488022 in cancer and developmental syndromes suggests that while deleterious in normal contexts, they may confer selective advantages in specific cellular environments (e.g., tumorigenesis).

---

### 6. **GWAS Findings**
No specific GWAS findings were retrieved for rs113488022, but its association with diseases like melanoma and thyroid carcinoma indicates its relevance in studies of cancer susceptibility.

---

### Conclusion
The evolutionary background of rs113488022 highlights its critical role in the BRAF gene, which is essential for cellular signaling. Its rarity and pathogenicity suggest strong purifying selection against deleterious mutations at this locus. However, its involvement in oncogenesis indicates that it may play a role in disease-driven evolution.

---

### 日本語での説明
#### 1. **変異の識別**
- **rs番号**: rs113488022
- **遺伝子名**: BRAF
- **染色体と位置**: 染色体7、位置140753336
- **HGVS表記**: 複数の表記があり、例としてNM_004333.6:c.1799T>G (p.Val600Gly)、NM_004333.6:c.1799T>C (p.Val600Ala)、NM_004333.6:c.1799T>A (p.Val600Glu)。
- **TogoVarリンク**: [rs113488022のTogoVarページ](https://togovar.org/variant/rs113488022)

#### 2. **疾患との関連性**
この変異は以下の疾患と関連しています：
- **メラノーマ**: 病原性（P）。
- **RASopathy**: 病原性（P）。
- **心顔皮症候群**: 疑わしい病原性（LP）。
- **乳頭状甲状腺癌**: 病原性（P）。
- **非小細胞肺癌**: 病原性（P）。

これらの関連性は、BRAF遺伝子が関与するMAPKシグナル伝達経路の重要性を示しています。

#### 3. **対立遺伝子頻度の比較**
- **世界的頻度**: gnomADエクソームデータセットで1.37 × 10⁻⁶と非常に稀。
- **日本人集団**: TogoVar APIから日本人集団の具体的な頻度データは取得されませんでした。

この変異の稀少性は、進化的に比較的新しい変異であるか、病原性の影響により強い負の選択を受けている可能性を示唆します。

#### 4. **機能的影響**
- **SIFTスコア**: 0.0（有害）
- **PolyPhenスコア**: 0.294～0.958（変異の種類による）
- **AlphaMissenseスコア**: 最大0.9927（病原性の可能性が高い）

この変異は、細胞成長や分化を調節する重要なBRAFタンパク質に影響を与えます。

#### 5. **進化的背景**
- **保存性**: BRAFのVal600残基は種を超えて高度に保存されており、タンパク質機能における重要性を示しています。
- **選択圧**: この位置の変異は疾患と関連しているため、健常な集団では浄化選択を受けている可能性があります。
- **疾患駆動型進化**: rs113488022のような病原性変異は、腫瘍形成など特定の細胞環境で選択的優位性を持つ可能性があります。

#### 6. **GWASの発見**
rs113488022に関する具体的なGWASの発見はありませんが、メラノーマや甲状腺癌との関連性は、癌感受性研究における重要性を示しています。

#### 結論
rs113488022の進化的背景は、BRAF遺伝子の重要性を強調しています。この変異の稀少性と病原性は、この遺伝子座での有害な変異に対する強い浄化選択を示唆します。一方で、腫瘍形成における役割は疾患駆動型進化の可能性を示しています。